Pacific Edge Advisors’s Merck MRK Stock Holding History

Pacific Edge Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,206	Closed	-$278K	–	41
2019 Q4	$278K	Buy	+3,206	New	+$263K	0.17%	42

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pacific Edge Advisors's MRK Position: Q1 2020 in Review

Pacific Edge Advisors sold out of Merck (MRK) in Q1 2020, closing a stake of 3,206 shares — an estimated $278K sold.

Pacific Edge Advisors first reported a position in MRK in Q4 2019 and held it in 1 quarter. The position peaked at $278K in Q4 2019. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

Pacific Edge Advisors reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
Pacific Edge Advisors sold 3,206 Merck shares in Q1 2020, an estimated $278K.
Pacific Edge Advisors first reported a position in Merck in Q4 2019 and held it in 1 quarter.
Pacific Edge Advisors's Merck position peaked at $278K in Q4 2019.
2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Pacific Edge Advisors's 13F filing for Q1 2020, filed 11 May 2020.